more_reports

Urovant Sciences Ltd.

UROV:NASDAQ

Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. The Company's lead product candidate, vibegron, is an oral, once-daily small molecule beta-3 agonist that is being evaluated for overactive bladder (OAB).

streetwise book logo Streetwise Company Fact Sheet

2024/11/26 3:23:50

(UROV:NASDAQ)